🇺🇸

US SEC Filing Intelligence

· daily

Insider Trading Pulse — July 09, 2026

The July 9, 2026 insider trading pulse reveals a stark divergence between broad-based insider buying at Taiwan Semiconductor Manufacturing Co. (TSMC) and significant insider selling at several US-based growth and healthcare firms. TSMC's CEO and 23 other top executives collectively purchased shares at $76.62, signaling strong management confidence despite a modest aggregate investment of ~$90K. This contrasts sharply with material insider sales at ResMed (CEO sold $1.09M under 10b5-1), Ceribell (CEO sold $469K under 10b5-1), and Pennant Group (CEO sold $128K after exercising cheap options). The day's activity is dominated by TSMC's coordinated insider buying, which represents a powerful vote of confidence in the semiconductor giant's outlook. Meanwhile, several smaller-cap firms saw insider selling that warrants close monitoring for potential headwinds. The data also shows routine option exercises and tax-withholding transactions at First US Bancshares and equity awards at First Northwest Bancorp, which are less informative for directional trading signals.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — July 09, 2026

The sole filing for the Dow 30 stream is Amazon.com, Inc.'s 8-K detailing a massive $24.923 billion multi-tranche debt offering closed on July 9, 2026. This capital raise, the largest single debt issuance by a Dow component in the period, signals a strategic shift in Amazon's capital allocation from internal cash flow to leverage, likely to fund aggressive AI infrastructure, M&A, or share buybacks. The neutral sentiment and high materiality (8/10) reflect a significant but non-operational event. The offering's structure—spanning maturities from 2029 to 2066 with coupons up to 6.250%—indicates Amazon is locking in long-term rates amid a potentially peaking interest rate environment, a move that could be accretive to shareholder value if deployed into high-ROI projects. No period-over-period comparisons, insider activity, or forward guidance were provided in this filing, limiting trend analysis but highlighting a singular, high-impact capital markets event.

1 medium 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — July 09, 2026

This intelligence stream reveals a severe cluster of corporate distress signals concentrated in micro-cap and pre-revenue biotech companies, with 5 of 8 filings involving Nasdaq/NYSE American non-compliance or delisting threats. The most critical development is the termination of the Shutterstock/Getty Images merger, a high-profile deal collapse driven by UK regulatory conditions, which signals heightened antitrust risk in digital content M&A. The remaining filings paint a bleak picture of liquidity crises: Kyverna Therapeutics is burning cash and extending loan draw deadlines with new revenue covenants, while Nauticus Robotics is issuing 10% cumulative preferred stock to raise capital, indicating desperate financing terms. The three Nasdaq deficiency notices (Onfolio, Hydrofarm, Prairie Operating) and one NYSE American compliance plan (Splash Beverage) represent a systemic wave of micro-cap distress, with all four companies trading below $1.00 and facing potential delisting. Period-over-period data from the enriched filings shows no positive revenue or margin trends—only deteriorating liquidity, increasing debt burdens, and regulatory overhang. The overarching theme is a 'distress cascade' in small-cap equities, where falling stock prices trigger listing compliance issues, which in turn restrict capital access and accelerate financial deterioration.

8 high priority 8 total filings
· daily

Global High-Priority Regulatory Events — July 09, 2026

This digest covers 45 filings from July 9, 2026, dominated by M&A activity, insolvency proceedings, and delisting risks. A clear theme is the surge in SPAC activity, with three SPACs (Bayview, byNordic, Plum) facing existential deadlines and one (Freedom Metals) launching a new IPO. The healthcare sector is active with two major acquisitions: IKS Health's $557M purchase of TruBridge (now delisted) and Virinchi's restructuring of its hospital business. The energy sector sees NextEra Energy's transformative $360M+ acquisition of Dominion Energy, while MARA Holdings is expanding its digital infrastructure with a 1-2 GW Texas site. Delisting risks are elevated, with five companies (Hydrofarm, Onfolio, Prairie Operating, Splash Beverage, and FREYR Battery) receiving deficiency notices or facing delisting. Insolvency proceedings show mixed outcomes: BPL had a petition dismissed (positive), while Unitech International's CoC rejected key resolutions (negative). Period-over-period data reveals revenue declines at Premier Explosives (-7% YoY) and Concord Enviro's subsidiary (-1.2% YoY), while SNA Milk showed strong 67.6% revenue growth. Capital allocation is focused on strategic acquisitions and internal restructuring, with limited buyback or dividend activity.

45 high priority 45 total filings
· daily

US SEC Filings Daily Market Digest — July 09, 2026

Today's filings reveal a market bifurcated between defensive positioning and selective growth. PepsiCo's Q2 results show a 6.4% revenue increase but organic growth of only 2.4%, with core margins contracting 40 bps, highlighting the consumer staples sector's struggle with volume declines. The collapse of the Shutterstock/Getty Images merger due to UK regulatory conditions signals heightened antitrust scrutiny on digital content consolidation. Capital markets remain active with Rivian's $1.32B equity raise providing a dilutive but necessary liquidity injection, while Enerpac's $472M acquisition of SFE Group at 10.6x EBITDA demonstrates continued appetite for industrial consolidation. Insider activity is notable with RH's CEO selling $20.7M in stock for personal liquidity, while institutional 13F filings show a pronounced shift toward fixed-income and inflation-protected ETFs, with aggregate holdings of over $4.5B across 13 filers heavily weighted toward defensive instruments. The SPAC market shows renewed activity with two new IPOs filing, though dilution risks remain significant. Overall, the data suggests investors are prioritizing balance sheet strength and cash flow visibility over growth at any price.

13 high priority 37 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — July 09, 2026

The two filings from Amazon and AutoZone both involve debt capital raising, signaling a sector-wide theme of accessing cheap credit to fund operations and growth. Amazon's massive $24.9 billion multi-tranche offering, its largest ever, suggests a strategic shift to lock in long-term financing, likely for AI infrastructure, M&A, or share buybacks, given its strong cash position. AutoZone's $850 million note issuance is more modest but indicates a similar need to refinance or fund working capital. No period-over-period financial comparisons, insider trading, or forward-looking guidance were disclosed in these 8-K filings, limiting trend analysis. The neutral sentiment and high materiality of Amazon's offering point to a significant but non-disruptive capital markets event. The lack of operational data in these filings means the digest focuses on capital structure implications and debt market conditions.

1 high priority 1 medium 2 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — July 09, 2026

The single filing in this digest for the S&P 500 Healthcare sector reveals a notable insider transaction at Medtronic plc, where the SVP and Chief HR Officer executed a planned sale of shares under a Rule 10b5-1 plan. While the transaction itself is modest in size (~$258K) and pre-planned, its occurrence in a major medical device company warrants attention as a potential signal of management sentiment at the executive level. The lack of other filings limits the ability to derive broad sector themes or period-over-period trends, but the insider activity provides a focused data point for assessing leadership conviction. The overall sentiment from this filing is negative, though the materiality is low, suggesting limited immediate market impact. Investors should monitor for any acceleration of insider selling or additional disclosures from Medtronic to gauge broader management confidence.

1 high priority 1 total filings
· daily

US Earnings Financial Results SEC Filings — July 09, 2026

The 19 filings reveal a sharply bifurcated earnings landscape. While large-cap consumer staples (PepsiCo) and select industrials (EACO, Enerpac) posted strong revenue and profit growth, the broader picture is one of distress across small-cap and growth names. A cluster of companies (KB Home, Byrna Technologies, Simply Good Foods, Nurix Therapeutics) reported severe profit declines or swings to losses, driven by demand drops, inventory write-downs, and impairment charges. Cash burn is a dominant theme, with several micro-cap firms (IIOT-OXYS, MADE IN USA, WidFit) showing zero or declining cash positions and negative working capital. Insider activity was sparse, but the aggressive share repurchases at Jefferies ($372M) and Simply Good Foods ($213M) signal management confidence at those firms. The most critical development is the collapse in gross margins at Byrna Technologies (from 61.6% to 10.9%) and the 74.6% net income drop at KB Home, which point to potential sector-specific headwinds in consumer durables and non-lethal defense. Portfolio-level patterns include a 'growth at any cost' theme in biotech (Nurix) and a 'profitless growth' theme in several small industrials (NTIC, Medinotec).

19 high priority 19 total filings
· daily

US Executive Compensation Proxy SEC Filings — July 09, 2026

This digest covers 10 proxy filings, with a dominant theme of corporate control events: four companies (Leggett & Platt, LivePerson, RE/MAX, EBR Systems) are pursuing transformative M&A, while two (Ascend Wellness, RYTHM) seek shareholder approval for capital structure changes. Executive compensation trends show significant compression at TuHURA Biosciences (CEO pay down 34% YoY, CFO down 37%), reflecting post-merger cost discipline. Insider activity is notably absent across most filings, but the heavy M&A pipeline creates binary risk/reward profiles. The most actionable signals come from the acquisition arbitrage opportunities in LivePerson (22% premium, collar structure) and RE/MAX (fixed exchange ratio with declining implied value), while governance concerns at TuHURA (infrequent committee meetings, late insider filings) and InnSuites (non-independent trustees) warrant monitoring. The fund repositioning at New York Life Investments offers a unique catalyst for international equity exposure.

10 high priority 10 total filings
· daily

US IPO Pipeline SEC S-1 Filings — July 09, 2026

The July 9, 2026, IPO pipeline is dominated by a mix of traditional SPAC, development-stage, and distressed issuers, alongside a major M&A-driven registration from NextEra Energy. The most significant theme is the surge in capital markets activity tied to transformative M&A, with the NextEra-Dominion S-4 representing a $60B+ implied deal and the Pulmatrix-Eos merger targeting a high-risk biotech combination. On the IPO front, Southern Cross Acquisition II (SPAC) and Leef Brands (cannabis) provide contrasting risk profiles, while Mitesco and Jaovi represent deeply distressed or micro-cap filings with going-concern warnings. Period-over-period data reveals mixed revenue trends: Leef Brands grew 15% YoY but with uneven segment performance, while Pulmatrix showed a 15% revenue increase but widening losses. The absence of insider trading activity in most filings is notable, though the Mitesco filing implies significant insider dilution via debt conversion. Overall, the pipeline signals a bifurcated market where quality issuers (NextEra) use registered exchanges for debt, while speculative and distressed entities test the IPO window.

7 high priority 7 total filings
· daily

US SEC Trading Suspension Halt Orders — July 09, 2026

All four filings in this digest highlight micro-cap companies facing imminent delisting or trading suspension from US exchanges (NASDAQ and NYSE American), driven by non-compliance with minimum bid price and shareholders' equity requirements. The cluster of events on July 2-9, 2026, signals a potential sector-wide liquidity and valuation crisis among small-cap issuers, with no positive period-over-period trends or insider buying to offset the negative outlook. The most critical development is the immediate delisting risk for Prairie Operating Co. if its stock trades at or below $0.10 for ten consecutive days, representing a binary event. Across the portfolio, all companies are in the 'cure period' with no forward-looking guidance or capital allocation improvements, suggesting a high probability of eventual suspension or delisting. The aggregate market implication is a bearish signal for micro-cap equities, as regulatory enforcement appears to be tightening on chronically non-compliant issuers.

4 high priority 4 total filings
· daily

US Executive Officer Management Changes SEC — July 09, 2026

This digest covers 25 filings from July 9, 2026, focused on executive and director changes. A clear theme is the strategic appointment of seasoned leaders from top-tier firms (Apple, Disney+, NetApp) to drive growth and operational scaling, particularly in the technology and energy sectors. Period-over-period data from Enovix and Pure Cycle shows strong revenue growth (49% and 60% YoY, respectively), but also highlights ongoing challenges like margin pressure and regulatory uncertainty. Notable insider activity includes a significant CEO transition at FuboTV and a shareholder activist resolution at Central Plains Bancshares. The most critical developments are the high-profile CEO appointment at FuboTV, the CFO transition at Philip Morris, and the operational leadership changes at Enovix and SoCalGas, all of which have clear market implications for their respective sectors. Portfolio-level patterns reveal a focus on internal promotions for CFO roles and a trend of appointing directors with deep industry or scientific expertise.

25 high priority 25 total filings
· daily

US Corporate Board Director Changes SEC Filings — July 09, 2026

The 25 filings reveal a significant wave of C-suite and board-level transitions across US-listed companies, with a notable concentration of CFO and COO changes, often tied to strategic pivots or operational scaling. Key period-over-period trends are limited but include Enovix's 49% YoY revenue growth and Pure Cycle's 60% YoY revenue surge, both linked to new leadership appointments aimed at accelerating manufacturing and land development. The most critical developments include the appointment of a former Disney+ president as CEO of FuboTV, signaling a strategic shift in the streaming space, and a shareholder activist-driven board appointment at Central Plains Bancshares, highlighting governance pressure in small-cap financials. Portfolio-level patterns indicate a focus on operational execution and commercial capability building, with several companies (UNFI, Enovix, SoCalGas) bringing in seasoned operators to drive growth. Insider activity is sparse, but the lack of insider selling in most transitions suggests orderly successions, though the departure of a 23-year veteran at UNFI and a key legal officer at Align Technology introduce execution risk.

25 high priority 25 total filings
· daily

USA Insider Trading Pulse — July 09, 2026

The July 9, 2026 insider trading pulse reveals a stark divergence in management conviction across sectors. The dominant theme is a massive, coordinated insider buying wave at Taiwan Semiconductor Manufacturing Co (TSMC), where 26 executives, including the Chairman/CEO, collectively purchased shares at $76.62, signaling extreme confidence in the company's near-term prospects. In sharp contrast, the healthcare and technology sectors show a pattern of high-level insider selling, with CEOs at ResMed, Pennant Group, and Ceribell executing significant sales under 10b5-1 plans, suggesting a desire to lock in gains. Financial insiders present a mixed picture, with some executives selling small lots while others are awarded shares. A notable positive signal comes from a 10% owner at AMG BBH Asset-Backed Credit Fund, who made a substantial $457K purchase. The overall portfolio-level trend points to a strong vote of confidence in semiconductor manufacturing, while caution flags are raised in healthcare and select financials, where insider selling is more prevalent.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — July 09, 2026

The July 9, 2026 M&A digest reveals a market bifurcated between high-conviction, strategic acquisitions (T3 Defense's purchase of Project 35, IKS Health's acquisition of TruBridge, MARA's land deal) and a wave of SPACs struggling to complete deals or facing existential deadlines. A clear theme is the capital-intensive pivot toward defense tech and digital infrastructure, with two major transactions totaling over $300M in implied value. Conversely, the SPAC market shows acute distress: Bayview Acquisition Corp faces Nasdaq delisting after a failed merger, while byNordic and Plum are burning through final extensions with high redemption risks. Period-over-period data from the enriched filings shows zero insider buying across all SPACs, contrasting with strong management conviction in the operating companies. The most actionable insight is the divergence between well-capitalized acquirers executing on strategy and SPACs with deteriorating timelines and no targets, creating both risk and opportunity for event-driven investors.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 09, 2026

Overnight filings reveal a mixed picture for US markets, with a notable cluster of insider selling at high-profile growth companies (Warby Parker, Airbnb, CrowdStrike) and a major deal collapse in the media sector (Shutterstock/Getty Images). The most significant positive signal is a broad-based equity grant program at General Mills, indicating strong long-term incentive alignment across its leadership team. A key risk theme emerges from the pledging of a large block of Applied Digital shares against a margin loan, creating potential for forced selling. On the turnaround front, Huineng Technology reported a dramatic swing to profitability, while ENDRA Life Sciences regained Nasdaq compliance, removing a near-term delisting risk. The overall tone is cautious, with insider selling outweighing buying, but the General Mills grants and the Cellectar Biosciences option awards suggest confidence in future growth at specific companies.

45 high priority 5 medium 50 total filings
· daily

DHS Homeland Security Contracts — July 08, 2026

Over a single day, the Department of Homeland Security awarded $480.3 million in contracts, all civilian, with an average signal strength of 5.2/10. The dominant theme is DHS/ICE spending on IT, cyber, and healthcare support services, accounting for four of the five awards. The highest-conviction signal is TRM LABS, INC.'s $94.7 million sole-source award for cyber analytical support, indicating a unique capability or urgent need, but its non-competitive structure and single-year term introduce execution risk. A key risk is the concentration of awards to ICE, which faces political and budgetary uncertainty that could impact contract performance and option exercises.

5 total filings
· daily

VA Healthcare & Services Contracts — July 08, 2026

The single contract digest for July 8, 2026, covers a $81.3 million modification awarded to TISTA SCIENCE AND TECHNOLOGY CORPORATION by the Department of Veterans Affairs, representing a purely civilian healthcare and services stream with no defense exposure. The contract carries a neutral signal with medium confidence, as key details on pricing, competition, and revenue impact are unknown, limiting actionable conviction. The dominant theme is VA healthcare IT or services spending, but the lack of competitive context or performance risk data makes this a watch-and-confirm item rather than a clear catalyst. Key risk is the absence of transparency on whether this is a sole-source or competed award, which could imply either a strong incumbent position or a protest-vulnerable non-competitive award.

1 total filings
· daily

HHS & Healthcare Contracts Intelligence — July 08, 2026

This digest covers a single $77.6M civilian contract awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the NIH National Cancer Institute (NCI). The contract is a cost-plus-fixed-fee delivery order for operational tasks, with options that could bring the total to $139.9M through August 2027. The award reinforces Leidos’s stable position in federal health R&D services, a sector with sustained funding from NIH. The neutral signal (strength 5/10, materiality 4/10) reflects moderate size and low risk, with no bullish or bearish catalysts. Key watch items include option year exercise by August 2026 and any modifications to the task order.

1 total filings
· daily

New Federal Contractors — July 08, 2026

This digest of 13 new federal contracts, totaling $1.16 billion in obligations, is overwhelmingly civilian (12 of 13 awards), with the Department of Homeland Security (DHS) as the dominant agency, accounting for five awards worth $447 million. The Department of Health and Human Services (HHS) is the second-largest spender, with three awards totaling $250 million. The highest-conviction signals are two bullish contracts: Deloitte & Touche LLP's $86.1 million HHS identity management win and ESIMPLICITY Inc's $80.1 million CMS data systems award, both reflecting competitive wins in stable, mandated IT programs. A key risk is the concentration of DHS awards to small or niche firms (TRM LABS, INSERSO, Amergis), which introduces execution and protest vulnerability, while the sole-source, fixed-price $94.7 million award to TRM LABS carries high execution risk. There is no defense-sector exposure in this batch, limiting actionable signals for defense-focused investors.

13 total filings